These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25029983)

  • 1. A lesson in participatory research for a rare mutation of cystic fibrosis.
    Kramer-Golinkoff E
    J Gen Intern Med; 2014 Aug; 29 Suppl 3(Suppl 3):S808-9. PubMed ID: 25029983
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient and public involvement in research: future challenges.
    Staniszewska S; Denegri S
    Evid Based Nurs; 2013 Jul; 16(3):69. PubMed ID: 23749800
    [No Abstract]   [Full Text] [Related]  

  • 3. Is community-based participatory research possible?
    Blumenthal DS
    Am J Prev Med; 2011 Mar; 40(3):386-9. PubMed ID: 21335275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and patient engagement in health research: What have we learned?
    Denegri S; Starling B
    CMAJ; 2021 Jul; 193(27):E1048-E1049. PubMed ID: 34253547
    [No Abstract]   [Full Text] [Related]  

  • 5. Promoting research in practice settings.
    Swartz MK
    J Pediatr Health Care; 2010; 24(2):69-70. PubMed ID: 20189058
    [No Abstract]   [Full Text] [Related]  

  • 6. A call for systematic data collection in tinnitus patients.
    Landgrebe M; Langguth B
    Otolaryngol Head Neck Surg; 2012 Feb; 146(2):343; author reply 343-4. PubMed ID: 24436488
    [No Abstract]   [Full Text] [Related]  

  • 7. Taskforce recommends coordinated effort to improve clinical research conduct and find highly effective CFTR-directed treatment for rare mutations.
    Solomon GM; Nichols DP
    J Cyst Fibros; 2019 Sep; 18(5):579-580. PubMed ID: 31279576
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug bests cystic-fibrosis mutation.
    Ledford H
    Nature; 2012 Feb; 482(7384):145. PubMed ID: 22318583
    [No Abstract]   [Full Text] [Related]  

  • 9. Breathing easier with combinations.
    Azvolinsky A
    Nat Biotechnol; 2015 Nov; 33(11):1128-30. PubMed ID: 26544137
    [No Abstract]   [Full Text] [Related]  

  • 10. Strengthening our knowledge base and research capacity for improved adolescent health in sub-Saharan Africa: a South-South-North collaboration.
    Bukenya JN; Canavan CR; Bärnighausen T; Fawzi WW
    Trop Med Int Health; 2020 Jan; 25(1):2-4. PubMed ID: 31777153
    [No Abstract]   [Full Text] [Related]  

  • 11. Basic science research vs. clinical research in cystic fibrosis: Has the pendulum swung too far?
    Coates AL; Bush A
    Pediatr Pulmonol; 2003 Sep; 36(3):175-7. PubMed ID: 12910577
    [No Abstract]   [Full Text] [Related]  

  • 12. Transformative mutation specific pharmacotherapy for cystic fibrosis.
    Sanders DB; Farrell PM
    BMJ; 2012 Jan; 344():e79. PubMed ID: 22232540
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutation-specific cystic fibrosis treatments on verge of approval.
    Dolgin E
    Nat Med; 2011 Apr; 17(4):396-7. PubMed ID: 21475213
    [No Abstract]   [Full Text] [Related]  

  • 14. Patients' participation in research projects as partners.
    Mazzoni D; van Leeuw B; Bednarova P; Marchiori F; Lerstrøm K
    Lupus; 2015 Jun; 24(7):776-7. PubMed ID: 25416697
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological treatment of the basic defect in cystic fibrosis.
    Roomans GM
    Cell Biol Int; 2014 Nov; 38(11):1244-6. PubMed ID: 24809326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quest for cystic fibrosis pharmacotherapy.
    Joo NS
    Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):861-2. PubMed ID: 18714439
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonstop treatment of cystic fibrosis.
    Dietz HC; Hamosh A
    Nat Med; 1996 Jun; 2(6):608-9. PubMed ID: 8640540
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological approaches to cystic fibrosis.
    Bandiera T; Galietta LJV
    Eur J Med Chem; 2021 Apr; 216():113240. PubMed ID: 33691259
    [No Abstract]   [Full Text] [Related]  

  • 19. A systematic review of the impact of patient and public involvement on service users, researchers and communities.
    Brett J; Staniszewska S; Mockford C; Herron-Marx S; Hughes J; Tysall C; Suleman R
    Patient; 2014; 7(4):387-95. PubMed ID: 25034612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFTR mutations and cystic fibrosis.
    Prescrire Int; 2013 Oct; 22(142):232. PubMed ID: 24298580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.